Rchr
J-GLOBAL ID:200901025669005238   Update date: Jun. 19, 2024

Mori Shuji

モリ シュウジ | Mori Shuji
Affiliation and department:
Job title: Professor
Homepage URL  (1): https://www.shujitsu.ac.jp/
Research field  (3): Clinical pharmacy ,  Other ,  Pharmacology
Research keywords  (6): サイトカイン ,  組織リモデリング ,  再生 ,  炎症 ,  分子標的薬 ,  抗体医薬
Research theme for competitive and other funds  (22):
  • 2021 - 2024 内因性AGEによる組織リモデリング増悪化機構の解明と新規標的治療法の創成
  • 2021 - 2024 炎症抑制性DAMPsの新規同定と炎症性疾患における病態生理学的意義の解明
  • 2018 - 2021 Study of the pathophysiological significance of endogenous AGE as an exacerbating factor for tissue remodeling, and the development of novel targeted therapy
  • 2015 - 2018 Mechanism for microthrombus formation on NETosis and development of therapy for ARDS.
  • 2015 - 2018 Roles of AGEs as exacerbation factor in pathogenesis of tissue remodeling and the development of novel targeted therapy
Show all
Papers (202):
  • Masahiro Watanabe, Takao Toyomura, Hidenori Wake, Takashi Nishinaka, Omer Faruk Hatipoglu, Hideo Takahashi, Masahiro Nishibori, Shuji Mori. Cationic ribosomal proteins can inhibit pro-inflammatory action stimulated by LPS+HMGB1 and are hindered by advanced glycation end products. Biotechnology and applied biochemistry. 2023
  • Takashi Nishinaka, Omer Faruk Hatipoglu, Hidenori Wake, Masahiro Watanabe, Takao Toyomura, Shuji Mori, Masahiro Nishibori, Hideo Takahashi. Different modulation of STING/TBK1/IRF3 signaling by advanced glycation end products. Archives of biochemistry and biophysics. 2023. 750. 109808-109808
  • Handong Qiao, Yuta Morioka, Dengli Wang, Keyue Liu, Shangze Gao, Hidenori Wake, Daiki Ousaka, Kiyoshi Teshigawara, Shuji Mori, Masahiro Nishibori. Protective effects of an anti-4-HNE monoclonal antibody against liver injury and lethality of endotoxemia in mice. European Journal of Pharmacology. 2023. 950. 175702-175702
  • Takao Toyomura, Masahiro Watanabe, Hidenori Wake, Takashi Nishinaka, Omer Faruk Hatipoglu, Hideo Takahashi, Masahiro Nishibori, Shuji Mori. Glycolaldehyde-derived advanced glycation end products promote macrophage proliferation via the JAK-STAT signaling pathway. Molecular Biology Reports. 2023. 50. 7. 5849-5858
  • Omer Faruk Hatipoglu, Takashi Nishinaka, Masahiro Nishibori, Masahiro Watanabe, Takao Toyomura, Shuji Mori, Kursat Oguz Yaykasli, Hidenori Wake, Hideo Takahashi. Histamine promotes angiogenesis through a histamine H1 receptor-PKC-VEGF-mediated pathway in human endothelial cells. Journal of pharmacological sciences. 2023. 151. 4. 177-186
more...
MISC (72):
  • 豊村隆男, 渡邊政博, 森秀治, 豊村隆男, 渡邊政博, 森秀治. Novel potential drug target for diabetic complications therapy, Glyoxalase I. 就実大学薬学雑誌. 2024. 11
  • 豊村隆男, 渡邊政博, 森秀治, 豊村隆男, 渡邊政博, 森秀治. Crosstalk between bone metabolism-related factor and immune regulatory system. 就実大学薬学雑誌. 2023. 10
  • TOYOMURA Takao, WATANABE Masahiro, MORI Shuji. TLR4-independent promotion of the osteoclast differentiation by detoxified LPS. 就実大学薬学雑誌. 2022. 9
  • 渡邊政博, 豊村隆男, 和氣秀徳, 西中崇, 逢坂大樹, 王登莉, 高橋英夫, 西堀正洋, 森秀治. 新規AGEs結合分子AGE-BP2がDAMPsの作用に与える影響の解析. 日本薬理学雑誌. 2021. 156. Supplement
  • 豊村隆男, 渡邊政博, 和氣秀徳, 逢坂大樹, 王登莉, 高橋英夫, 西堀正洋, 森秀治. 終末糖化産物AGE2による細胞増殖効果とTLR2による制御. 日本生化学会大会(Web). 2020. 93rd
more...
Books (14):
  • DAMPsとしてのHMGB1と創薬
    医学のあゆみ 2018
  • AGEs結合因子の同定とその病理学的解析
    ラクトフェリン2017 2017
  • 生活習慣病の増悪化因子「HMGB1,AGEs-RAGE系」に対する創薬プラットフォーム構築
    日本薬理学雑誌 2014
  • High Mobility Group Box-1を治療標的とする脳梗塞治療
    日本薬理学雑誌 2009
  • 炎症における凝固系プロテアーゼの制御
    プロテアーゼインヒビター臨床編 2005
more...
Works (1):
  • 組織リモデリングや炎症・再生に働く活性因子群の分子機能解析と創薬・薬理(分子標的薬)
Education (1):
  • - 1989 Okayama University The Graduate School of Natural Science and Technology
Professional career (2):
  • Ph.D. (Okayama University)
  • Master of pharmaceutical Sciences (Okayama University)
Work history (7):
  • 2012 - Shujitsu University
  • 2006 - Shujitsu University School of Pharmacy
  • 2001 - Okayama University Graduate School of Medicine , Dentistry and Pharmaceutical Sciences
  • 1998 - Okayama University Medical School
  • 1996 - ニュージャージー医科歯科大学 在外研究員
Show all
Committee career (2):
  • - 現在 日本生化学会 学術評議員
  • 日本薬理学会 学術評議員
Awards (1):
  • 2009 - 平成21年度 全国発明表彰 「21世紀発明奨励賞」 受賞名「抗体医薬による脳梗塞の新規治療法の発明」
Association Membership(s) (7):
THE JAPANESE SOCIETY ON THROMBOSIS AND HEMOSTASIS ,  日本炎症再生医学会 ,  日本ヒスタミン学会 ,  THE MOLECULAR BIOLOGY SOCIETY OF JAPAN ,  日本生化学会 ,  日本薬学会 ,  日本薬理学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page